These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34976183)

  • 21. Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy.
    Foerster R; Kluck R; Rief H; Rieken S; Debus J; Lindel K
    Radiat Oncol; 2014 Jun; 9():141. PubMed ID: 24941899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival outcomes and patterns of failure in women with stage IIIC
    Lee JK; Mahan M; Hanna RK; Elshaikh MA
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer.
    Sapienza LG; Ning MS; de la Pena R; McNew LK; Jhingran A; Georgeon L; Rasool N; Gomes MJL; Abu-Isa E; Baiocchi G
    Int J Gynecol Cancer; 2020 Oct; 30(10):1535-1541. PubMed ID: 32376738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysis.
    Wang W; Zou L; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Sun S; Jin M; Zhang F; Hou X; Wei L; Hu K
    BMC Cancer; 2021 Jul; 21(1):774. PubMed ID: 34217240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage Versus Adjuvant Radiation Treatment for Women With Early-Stage Endometrial Carcinoma: A Matched Analysis.
    Vance S; Burmeister C; Rasool N; Buekers T; Elshaikh MA
    Int J Gynecol Cancer; 2016 Feb; 26(2):307-12. PubMed ID: 26745700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
    Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
    Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
    Narasimhulu DM; Cope A; Riaz IB; Petersen I; Cilby W; Langstraat C; Glaser G; Kumar A; Cappuccio S; Murad MH; West C; Mariani A
    Int J Gynecol Cancer; 2020 Jun; 30(6):797-805. PubMed ID: 32221021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer.
    Hathout L; Wang Y; Wang Q; Vergalasova I; Elshaikh MA; Dimitrova I; Damast S; Li JY; Fields EC; Beriwal S; Keller A; Kidd EA; Usoz M; Jolly S; Jaworski E; Leung EW; Donovan E; Taunk NK; Chino J; Natesan D; Russo AL; Lea JS; Albuquerque KV; Lee LJ
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1423-1431. PubMed ID: 33677053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysis.
    Gupta V; McGunigal M; Prasad-Hayes M; Kalir T; Liu J
    Gynecol Oncol; 2017 Jan; 144(1):119-124. PubMed ID: 27793358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy.
    Abakay CD; Arslan S; Kurt M; Cetintas S
    Radiat Oncol J; 2022 Jun; 40(2):103-110. PubMed ID: 35796113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment outcomes after adjuvant radiotherapy following surgery for patients with stage I endometrial cancer.
    Kim J; Lee KJ; Park KR; Ha B; Kim YJ; Jung W; Lee R; Kim SC; Moon HS; Ju W; Kim YH; Lee J
    Radiat Oncol J; 2016 Dec; 34(4):265-272. PubMed ID: 27703126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival after relapse in patients with endometrial cancer: results from a randomized trial.
    Creutzberg CL; van Putten WL; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van den Bergh AC; van der Steen-Banasik E; Beerman H; van Lent M;
    Gynecol Oncol; 2003 May; 89(2):201-9. PubMed ID: 12713981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
    Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
    Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
    J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
    Klopp AH; Jhingran A; Ramondetta L; Lu K; Gershenson DM; Eifel PJ
    Gynecol Oncol; 2009 Oct; 115(1):6-11. PubMed ID: 19632709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy.
    Jereczek-Fossa B; Badzio A; Jassem J
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):405-13. PubMed ID: 10974454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer.
    Donovan E; Reade CJ; Eiriksson LR; Pond GR; Arora N; Elit L; Memon S; Voruganti S; Patel M; Jimenez W; John M; Kong I
    Cureus; 2018 Sep; 10(9):e3387. PubMed ID: 30524915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.